A profile of diabetes in pacific island countries and territories

Diabetes Research and Clinical Practice

Volumn 107, Issue 2, 2015, Pages 233-246

  Win Tin, Si Thu ^a   Lee, Crystal Man Ying ^a   Colagiuri, Ruth ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Complications; Cost; Diabetes prevalence; Pacific Islands; Quality of life

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

AGE DISTRIBUTION; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL EFFECTIVENESS; DEMOGRAPHY; DIABETES CARE; DIABETES MELLITUS; DIABETES RELATED MACROVASCULAR COMPLICATION; DIABETES RELATED MICROVASCULAR COMPLICATION; DIABETIC RETINOPATHY; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; FAMILY HISTORY; GLYCEMIC CONTROL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PACIFIC ISLAND COUNTRY AND TERRITORY; PACIFIC ISLANDS; PATIENT CARE; PATIENT EDUCATION; PHYSICAL INACTIVITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SOCIOECONOMICS; SYSTEMATIC REVIEW; TREND STUDY; URBAN POPULATION; VASCULAR DISEASE; WAIST HIP RATIO; ADULT; AGED; BLOOD; COMPLICATION; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; OVERWEIGHT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PACIFIC ISLANDS; PREVALENCE; QUALITY OF LIFE; RISK FACTORS;

EID: 84922041600     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.10.010     Document Type: Review

References (84)

1. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. International Diabetes Federation The diabetes atlas 2013, IDF, Brussels, Belgium. 6th ed.
3. Win Tin S.T., Kenilorea G., Gadabu E., Tassserei J., Colagiuri R. The prevalence of diabetes complications and associated risk factors in Pacific Island countries. Diabetes Res Clin Pract 2014, 103:114-118.
4. Colagiuri R. Building capacity to reduce diabetes complications in the Pacific: the Vanuatu experience so far. Pract Diab Int 2006, 23:343-346.
5. Asante A., Negin J., Hall J., Dewney J., Zwi A. Analysis of policy implications and challenges of the Cuban health assistance program related to human resources for health in the pacific. BioMed Cent 2012, 10(1):1-9.
6. Chan J.C.N., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301(20):2129-2140.
7. Ramachandran A., Ma R.C.W., Snehalatha C. Diabetes in Asia. Lancet 2010, 375:408-418.
8. Mbanya J.C., Motala A.A., Sobngwi E., Assah F.K., Enoru S.T. Diabetes in sub-Saharan Africa. Lancet 2010, 375(9733):2254-2266.
9. Zabetian A., Keli H.M., Echouffo-Tcheugui J.B., Narayan K.M.V., Ali M.K. Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract 2013, 101:106-122.
10. Sunia F., Neil P. Prevalence and causes of diabetes in Pacific people. Pacific Health Dialog 2003, 10:90-98.
11. Chan J.C.N., Cho N.H., Tajima N., Shaw J. Diabetes in the Western Pacific Region - past, present and future. Diabetes Res Clin Pract 2013, 10.1016/j.diabres.2013.11.012.
12. World Health Organization Global status report on noncommunicable diseases 2010, WHO, (retrieved from 27.10.13). http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
13. World Health Organization. Non-communicable diseases in the Western Pacific Region: profile. WHO. (retrieved from 27.10.13). http://www.wpro.who.int/noncommunicable_diseases/documents/ncd_in_wpr/.
14. Secretariat of the Pacific Community Study of risk factors for chronic non-communicable diseases in Willis and Futuna 2010, SPC, (retrieved from 27.10.13). http://www.spc.int/en/featured-publications.html.
15. World Health Organization STEPS country reports. (retrieved from 31.01.2014). http://www.who.int/chp/steps/reports/en/.
16. Collins V.R., Dowse G.K., Zimmet P.Z. Evidence against association between parity and NIDDM from five population groups. Diabetes Care 1991, 14:975-981.
17. Hodge A.M., Dowse G.K., Zimmet P.Z. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996, 13:441-449.
18. Brian G., Ramke J., Maher L., Page A., Szetu J. The prevalence of diabetes among adults aged 40 years and over in Fiji. N Z Med J 2010, 123:68-75.
19. King H., Finch C., Koki G., King L.F., Alpers M., Zimmet P. Glucose tolerance in Papua New Guinea: comparison of Austronesian and non-Austronesian communities of Karkar Island. Diabet Med 1991, 8:481-488.
20. Russell-Jones D.L., Hoskins P., Kearney E., Morris R., Katoaga S., Slavin B., et al. Rural/urban differences of diabetes - impaired glucose tolerance, hypertension, obesity, glycosolated haemoglobin, nutritional proteins, fasting cholesterol and apolipoproteins in Fijian Melanesians over 40. Q J Med 1990, 74:75-81.
21. Taylor R., Jalaludin B., Levy S., Montaville B., Gee K., Sladden T. Prevalence of diabetes, hypertension and obesity at different levels of urbanisation in Vanuatu. Med J Aust 1991, 155:86-90.
22. Taylor R., Badcock J., King H., Pargeter K., Zimmet P., Fred T., et al. Dietary intake, exercise, obesity and noncommunicable disease in rural and urban populations of three pacific island countries. J Am Coll Nutr 1992, 11:283-293.
23. Collins V.R., Dowse G.K., Toelupe P.M., Imo T.T., Aloaina F.L., Spark R.A., et al. Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 1994, 17:288-296.
24. Dowse G.K., Spark R.A., Mavo B., Hodge A.M., Erasmus R.T., Gwalimu M., et al. Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust 1994, 160:767-774.
25. Papoz L., Barny S., Simon D., Ledoux F., Merger C., Gerrnain M., et al. Prevalence of diabetes mellitus in New Caledonia: ethnic and urban-rural differences. Am J Epidemiol 1996, 143:1018-1024.
26. Edelstein S.L., Knowler W.C., Bain R.P., Andres R., Barrett-Connor E.L., Dowse G.K., et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997, 46:701-710.
27. Colagiuri S., Colagiuri R., Na'ati S., Muimuiheata S., Hussain Z., Palu T. The prevalence of diabetes in the kingdom of Tonga. Diabetes Care 2002, 25:1378-1383.
28. Shmulewitz D., Auerbach S.B., Lehner T., Blundell M.L., Winick J.D., Youngman L.D., et al. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered 2001, 51:8-19.
29. Durand Z.W. Age of onset of obesity, diabetes and hypertension in Yap State, Federated States of Micronesia. Pacific Health Dialog 2007, 14:165-169.
30. Khambalia A., Phongsavan P., Smith B.J., Keke K., Dan L., Fitzhadinge A., et al. Prevalence and risk factors of dibetes and imparied fasting glucose in Nauru. BMC Public Health 2011, 11:719.
31. Pinhey T.K., Heathcote G.M., Craig U.K. Health status of diabetic persons in an Asian-Pacific population: evidence from Guam. Ethn Dis 1997, 7:65-71.
32. Franzco B.G., Fischer-Harder K., Sikivou B., Qoqonokana M.Q., Szetu J., Ramke J. Diabetic eye disease among adults in Fiji with self-reported diabetes. Clin Exp Ophthalmol 2010, 38:867-874.
33. Brooks B., Chong R., Ho I., Capstick F., Molyneaux L., Oo T.T., et al. Diabetic retinopathy and nephropathy in Fiji: comparison with data from an Australian diabetes centre. Aust N Z J Ophthalmol 1999, 27:9-13.
34. Collins V.R., Dowse G.K., Plehwe W.E., Imo T.T., Toelupe P.M., Taylor H.R., et al. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 1995, 18:1140-1149.
35. Erasmus R.T., Okesina B. Microalbuminuria in a clinic population of type 2 Melanesian diabetics: relationship to glycaemic control, blood pressure and duration of diabetes. Cent Afr J Med 1999, 45:291-294.
36. Humphrey A.R., Dowse G.K., Thoma K., Zimmet P.Z. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention - a 12-year follow-up study in Nauru. Diabetes Care 1996, 19:710-714.
37. Falconer D.G., Buckley A., Colagiuri R. Counting the cost of type 2 diabetes in Vanuatu. Diabetes Res Clin Pract 2010, 87:92-97.
38. Carter K., Hufanga S., Rao C., Akauola S., Lopez A.D., Rampatige R., et al. Causes of death in Tonga: quality of certification and implications for statistics. Popul Health Metr 2012, 10:4.
39. Collins V.R., Dowse G.K., Cabealawa S., Ram P., Zimmet P.Z. High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Int J Epidemiol 1996, 25:59-69.
40. Suguitan G., McDuffie K.Y. Diabetes related preventive care practices, Guam 2001-2003. MMWR Morb Mortal Wkly Rep 2005, 54:333-335.
41. Erasmus R.T., Sinha A.K. Assessment of long-term glycaemic control in diabetic patients attending Port Moresby General Hospital. P N G Med J 1995, 38:16-19.
42. Kuruvatti J., Price H. Life is sweet in Fiji: the availability of diabetes healthcare and health education, and diabetes awareness amongst diabetic patients in Fiji. Pract Diabetes Int 2002, 19:160-163. BMC Public Health 2011;11:719.
43. David A.M., Rubio J.M.C., Luces P.S., Zabala R.V., Roberto P. Getting the patient's perspective: a survey of diabetes services on Guam. Hawaii Med J 2010, 69:45-49.
44. Qoqonokana M.Q., Brian G., Ramke J., Garcia J., Szetu J. Diabetic retinopathy in a hospital eye clinic population in Honiara, Solomon Islands. Clin Exp Ophthalmol 2010, 38:862-866.
45. Win Tin S.T., Gadabu E., Iro G., Tasserei J., Colagiuri R. Diabetes related amputations in Pacific Islands countries: a root cause analysis of precipitating events. Diabetes Res Clin Pract 2013, 100:230-234.
46. Lesley J., Manning L.A., Ogle G.D. A survey of diabetes services in hospitals in Papua New Guinea. P N G Med J 2001, 44:88-95.
47. Xu Y., Wang L., He J., Bi Y., Li M., Wang T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
48. Eledrisi M., Alhaj B., Rehmani R., Alotaibi M., Mustafa M., Akbar D., et al. Quality of diabetes care in Saudi Arabia. Diabetes Res Clin Pract 2007, 78(1):145-146.
49. Alberti H., Boudriga N., Nabli M. "Damm sokkor": factors associated with the quality of care of patients with diabetes: a study in primary care in Tunisia. Diabetes Care 2007, 30(8):2013-2018.
50. Matoto V., Viney K., Roseveare C., Colagiuri R., Marais B.J. Burden and spectrum of disease in people with diabetes in Tonga. Public Health Action 2014, 4(2):S44-S49.
51. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1349.
52. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
53. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20 year follow-up study. Lancet 2008, 371:1782-1789.
54. Tight blood pressure control and rik of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. UK Prospective Diabetes Study Group.
55. Gray A., Raikou M., McGuire A., Fenn P., Stevens R., Cull C., et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial: UKPDS 41. BMJ 2000, 320:1373-1378.
56. Cost-effectiveness of Intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 daibetes. JAMA 2002, 287:2542-2551. The CDC Diabetes Cost-effectiveness Group.
57. World Health Organization. Western Pacific Region: non-communicable diseases. http://www.wpro.who.int/mediacentre/factsheets/fs_20120926e/en/.
58. United Nation A/66/2 political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases 2011, (retrieved from 12.8.2014). http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf.
59. World Health Organization Global monitoring framework for the prevention and control of non-communicable diseases 2013, (retrieved from 12.8.2014). http://www.who.int/nmh/global_monitoring_framework/en/.
60. World Health Organization Global action plan for the prevention and control of non-communicable diseases 2013-2030 2013, (retrieved from 12.8.2014). http://www.who.int/nmh/events/ncd_action_plan/en/.
61. Doran C. An economic assessment of inpatient NCD costs in Kiribati, Tonga and Vanuatu. Pacific Action for health project report. Secretariat of the Pacific Community 2003.
62. The economic costs of non-communicable diseases in the Pacific Islands; a rapid stocktake of the situation in Samoa, Tonga and Vanauru. The World Bank Report 2012, (retrieved from 23.1.2014). http://www.worldbank.org/content/dam/Worldbank/document/the-economic-costs-of-noncommunicable-diseases-in-the-pacific-islands.pdf.
63. Benjamin A.L. Community screening for diabetes in the National Capital District, Papua New Guinea: is betelnut chewing a risk factor for diabetes?. P N G Med J 2001, 44:101-107.
64. Yamada S., Dodd A., Soe T., Chen T.H., Bauman K. Diabetes mellitus prevalence in out-patient Marshallese adults on Ebeye Island, Republic of the Marshall Islands. Hawaii Med J 2004, 63:45-51.
65. World Health Organization WHO expert committee on diabetes mellitus. Second report 1980, WHO, Geneva, Technical report series no. 646.
66. World Health Organization Diabetes mellitus: report of a WHO study group 1985, World Health Organization, Geneva.
67. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva.
68. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
69. Department of Health American Samoa American Samoa STEPS Noncommunicable Diseases Risk factors Survey 2007, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/american_samoa/en/.
70. Ministry of Health Cook Islands Cook Islands STEPS noncommunicable disease risk factors survey 2011, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/2003_CookIslands_STEPS_Report.pdf.
71. Ministry of Health Fiji, Fiji School of Medicine, World Health Organization Fiji non-communicable diseases (NCD) STEPS survey 2002, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/FijiSTEPSReport.pdf.
72. Ministry of Health French Polynesia French Polynesia STEPS noncommunicable disease risk factors survey 2010, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/french_polynesia/en/index.html.
73. Ministry of Health and Social Affairs Federated States of Micronesia Federate State of Micronesia (Pohnpei) STEPS Noncommunicable Disease Risk Factors Survey 2008, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/STEPS_Report_Micronesia.pdf.
74. Ministry of Health and Medical Services Kiribati Kiribati NCD risk factors STEPS report 2009, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/kiribati_STEPS_report_2004-6.pdf.
75. Ministry of Health Republic of the Marshall Islands Marshall Islands STEPS noncommunicable disease risk factors survey 2002, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/2002_Marshall_Islands_STEPS-Report.pdf.
76. Ministry of Health Nauru Nauru STEPS noncommunicable disease risk factors survey 2007, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/nauru/en/.
77. Department of Health Niue Niue STEPS noncommunicable disease risk factors survey 2013, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/niue/en/.
78. Ministry of Health Papua New Guinea Papua New Guinea STEPS noncommunicable disease risk factors survey fact sheet 2007-2008, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/papua_new_guinea/en/.
79. Ministry of Health and Medical Services Solomon Islands Solomon Islands STEPS noncommunicable disease risk factors survey 2010, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/2006_Solomon_Islands_STEPS_Report.pdf.
80. Ministry of Health Samoa Samoa STEPS noncommunicable disease risk factors survey fact sheet 2002, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/samoa/en/.
81. Ministry of Health Tonga Tonga STEPS noncommunicable disease risk factors survey 2012, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/2004_TongaSTEPSReport.pdf.
82. Ministry of Health Tokelau Tokelau STEPS noncommunicable disease risk factors survey 2007, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/STEPS_Report_Tokelau.pdf.
83. Ministry of Health Vanuatu Vanuatu STEPS noncommunicable disease risk factors survey 2013, World Health Organization, Geneva, (retrieved from 31.01.14). http://www.who.int/chp/steps/vanuatu/en/.
84. Abidi S.M., Negrete H.O., Zahid I., Bennett P.H., Nelson R.G. Diabetic end-stage renal disease in the indigenous population of the Commonwealth of the Northern Mariana Islands. Nephrology 2005, 10:291-295.